Biological treatment for use for clinical, medicinal and the therapeutic treatment of Friedreich's Ataxia and genetic disorders; biological preparations for the treatment of Friedreich's Ataxia and genetic disorders; biological preparations and biospecific reagents for use in immunotherapy for the treatment of Friedreich's Ataxia and genetic disorders; biological drugs for use for clinical, medicinal and therapeutic treatment of Friedreich's Ataxia; biological drugs for treatment of genetic diseases and Friedreich's Ataxia; biological drugs for use in treating Friedreich's Ataxia and autoimmunity disorders and diseases; gene therapy products, namely, therapeutics for the treatment of Friedreich's Ataxia, autoimmune, immune system diseases and disorders; pharmaceutical preparations for human use for the treatment of Friedreich's Ataxia; therapeutic and medical diagnostic agents and preparations for use in therapies for Friedreich's Ataxia and autoimmunity; therapeutic and diagnostic agents, preparations and substances for medical purposes for targeting application to immunotherapies and therapeutic and diagnostic agents
Pharmaceuticals